WO2001023587A3 - Nouveau compose - Google Patents

Nouveau compose Download PDF

Info

Publication number
WO2001023587A3
WO2001023587A3 PCT/GB2000/003680 GB0003680W WO0123587A3 WO 2001023587 A3 WO2001023587 A3 WO 2001023587A3 GB 0003680 W GB0003680 W GB 0003680W WO 0123587 A3 WO0123587 A3 WO 0123587A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
hetaa37
polynucleotides
disclosed
methods
Prior art date
Application number
PCT/GB2000/003680
Other languages
English (en)
Other versions
WO2001023587A2 (fr
Inventor
Christopher Donald Southan
Original Assignee
Smithkline Beecham Plc
Christopher Donald Southan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Christopher Donald Southan filed Critical Smithkline Beecham Plc
Priority to EP00962730A priority Critical patent/EP1144654A3/fr
Publication of WO2001023587A2 publication Critical patent/WO2001023587A2/fr
Publication of WO2001023587A3 publication Critical patent/WO2001023587A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des polypeptides et des polynucléotides HETAA37, ainsi que des procédés de production de ces polypeptides par des techniques recombinantes. L'invention concerne également des procédés d'utilisation des polypeptides et des polynucléotides HETAA37, dans la conception de protocoles de traitement du cancer, d'inflammations, de l'asthme, d'affections cachectisantes, de l'athérosclérose, des accidents cérébrovasculaires, du diabète, de l'arthrite, de la maladie d'Alzheimer d'autres affections neurodégénératives, et d'autres troubles neurologiques, entre autres, et enfin des tests de diagnostic pour les conditions décrites ci-dessus.
PCT/GB2000/003680 1999-09-25 2000-09-25 Nouveau compose WO2001023587A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP00962730A EP1144654A3 (fr) 1999-09-25 2000-09-25 Nouveau compose

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9922835.5 1999-09-25
GBGB9922835.5A GB9922835D0 (en) 1999-09-25 1999-09-25 Novel compounds

Publications (2)

Publication Number Publication Date
WO2001023587A2 WO2001023587A2 (fr) 2001-04-05
WO2001023587A3 true WO2001023587A3 (fr) 2001-10-11

Family

ID=10861681

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2000/003680 WO2001023587A2 (fr) 1999-09-25 2000-09-25 Nouveau compose

Country Status (3)

Country Link
EP (1) EP1144654A3 (fr)
GB (1) GB9922835D0 (fr)
WO (1) WO2001023587A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998037418A2 (fr) * 1997-02-25 1998-08-27 Corixa Corporation Composes servant au diagnostic immunologique de cancer de la prostate et leurs procedes d'utilisation
EP0936270A2 (fr) * 1998-02-12 1999-08-18 Basf Aktiengesellschaft Sérine protéase de la prostate
US5955306A (en) * 1996-09-17 1999-09-21 Millenium Pharmaceuticals, Inc. Genes encoding proteins that interact with the tub protein

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955306A (en) * 1996-09-17 1999-09-21 Millenium Pharmaceuticals, Inc. Genes encoding proteins that interact with the tub protein
WO1998037418A2 (fr) * 1997-02-25 1998-08-27 Corixa Corporation Composes servant au diagnostic immunologique de cancer de la prostate et leurs procedes d'utilisation
EP0936270A2 (fr) * 1998-02-12 1999-08-18 Basf Aktiengesellschaft Sérine protéase de la prostate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PETER S NELSON ET AL: "Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA,NATIONAL ACADEMY OF SCIENCE. WASHINGTON,US, vol. 96, no. 6, 16 March 1999 (1999-03-16), pages 3114 - 3119, XP002141959, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
EP1144654A3 (fr) 2002-02-27
WO2001023587A2 (fr) 2001-04-05
GB9922835D0 (en) 1999-11-24
EP1144654A2 (fr) 2001-10-17

Similar Documents

Publication Publication Date Title
EP0855444A3 (fr) Proteinase aspartique 2
WO1998031799A3 (fr) Polynucleotides et polypeptides codant des recepteurs
CA2096911A1 (fr) Protease associee a la proteine precurseur d'amyloide
AU5798199A (en) Two-stage process for the production of 1,3-propanediol by catalytic hydrogenation of 3-hydroxypropanal
EP0848062A3 (fr) Protéase aspartique ASP1
EP0897002A3 (fr) U62317, une protéine avec un domaine se liant à JNK
EP0879889A3 (fr) Un membre de la famille de l'interleukine-1,iL-1 delta
WO2001023587A3 (fr) Nouveau compose
EP0875572A3 (fr) CRFG-1a, cible et marqueur pour l'insuffisance rénale chronique
EP0879888A3 (fr) Polypeptides patched-2 et polynucléotides et leurs procédés de fabrication
WO2001023589A3 (fr) Nouvelle ubiquitine protease humaine nommee 23431
EP0875577A3 (fr) Gène de la métalloprotéinase matricielle du type à membrane-5
EP0874050A3 (fr) Ligand d'integrin ITGL-TSP
EP0897009A3 (fr) HKABY60 polypeptides
EP0913472A3 (fr) Homologue humain de LIG-1 (HLIG-1)
WO2001075009A3 (fr) Nouveau polypeptide, sérine arnt synthétase 27, et polynucléotide codant pour ce polypeptide
WO2001083688A3 (fr) Nouveau polypeptide, sous-unite humaine 13 phosphatidylinositol-4-phosphate-5-kinase ii beta, et polynucleotide codant pour ce polypeptide
WO2001096525A3 (fr) Nouveau polypeptide, unite de transposition pogo 18, et polynucleotide codant ce polypeptide
WO1998042833A3 (fr) Polypeptides et polynucleotides de la famille des canaux de potassium kv
WO2001040484A3 (fr) Nouveau polypeptide, serine protease humaine 64 atp-dependante, et polynucleotide codant pour ce polypeptide
WO2001079439A3 (fr) Nouveau polypeptide, proteine humaine de reception cannabinoide 19, et un polynucleotide codant pour ce polypeptide
WO2001075060A3 (fr) Nouveau polypeptide, cysteine protease humaine 9, et polynucleotide codant pour ce polypeptide
WO2001075054A3 (fr) Nouveau polypeptide, facteur humain de regulation 30 de la transcription de la microglobuline, et polynucleotide codant pour ce polypeptide
WO2001075053A3 (fr) Nouveau polypeptide, chaperonine humaine 14, et polynucleotide codant pour ce polypeptide
WO2002000823A3 (fr) Nouveau polypeptide, proteine d'activation enzymatique ras gtp 9.57, et polynucleotide codant ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2000962730

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWP Wipo information: published in national office

Ref document number: 2000962730

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2000962730

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP